Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 9738745, 20 pages
https://doi.org/10.1155/2017/9738745
Research Article

Myricitrin Modulates NADPH Oxidase-Dependent ROS Production to Inhibit Endotoxin-Mediated Inflammation by Blocking the JAK/STAT1 and NOX2/p47phox Pathways

1Anhui Province Key Laboratory of Active Biological Macromolecules, Wannan Medical College, Wuhu, China
2Department of Biochemistry, Wannan Medical College, Wuhu 241002, China
3Department of Forensic Medicine, Wannan Medical College, Wuhu, China

Correspondence should be addressed to Yao Zhang

Received 10 October 2016; Revised 24 December 2016; Accepted 4 January 2017; Published 20 June 2017

Academic Editor: Ilaria Peluso

Copyright © 2017 Shimei Qi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Q. Feng, Y. Ren, Y. Wang et al., “Anti-inflammatory effect of SQC-beta-CD on lipopolysaccharide-induced acute lung injury,” Journal of Ethnopharmacology, vol. 118, no. 1, pp. 51–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. P. E. Parsons, G. S. Worthen, E. E. Moore, R. M. Tate, and P. M. Henson, “The association of circulating endotoxin with the development of the adult respiratory distress syndrome,” The American Review of Respiratory Disease, vol. 140, no. 2, pp. 294–301, 1989. View at Publisher · View at Google Scholar
  3. S. U. Qing, Y. C. Zheng, B. Zhao, S. J. Feng, Y. Zhang, and N. Wang, “Survival analysis of patients with acute lung injury and acute respiratory distress syndrome,” Chinese General Practice, vol. 16, no. 7, pp. 2222–2226, 2013. View at Google Scholar
  4. Y. Li, X. Li, G. Liu et al., “Fucosterol attenuates lipopolysaccharide-induced acute lung injury in mice,” The Journal of Surgical Research, vol. 195, no. 2, pp. 515–521, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Yamamoto, S. Sato, H. Hemmi et al., “Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway,” Science, vol. 301, no. 5633, pp. 640–643, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. D. De Nardo, “Toll-like receptors: activation, signalling and transcriptional modulation,” Cytokine, vol. 74, no. 2, pp. 181–189, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. J. W. Jeong, H. H. Lee, M. H. Han, G. Y. Kim, W. J. Kim, and Y. H. Choi, “Anti-inflammatory effects of genistein via suppression of the toll-like receptor 4-mediated signaling pathway in lipopolysaccharide-stimulated BV2 microglia,” Chemico-Biological Interactions, vol. 212, no. 5, pp. 30–39, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Chung, E. Uchida, T. C. Grammer, and J. Blenis, “STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation,” Molecular and Cellular Biology, vol. 17, no. 11, pp. 6508–6516, 1997. View at Publisher · View at Google Scholar
  9. S. Becker, B. Groner, and C. W. Müller, “Three-dimensional structure of the Stat3beta homodimer bound to DNA,” Nature, vol. 394, no. 6689, pp. 145–151, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Woetmann, M. Nielsen, S. T. Christensen et al., “Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 19, pp. 10620–10625, 1999. View at Google Scholar
  11. L. Samavati, R. Rastogi, W. Du, M. Hüttemann, A. Fite, and L. Franchi, “STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria,” Molecular Immunology, vol. 46, no. 8-9, pp. 1867–1877, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Luu, C. J. Greenhill, A. Majoros, T. Decker, B. J. Jenkins, and A. Mansell, “STAT1 plays a role in TLR signal transduction and inflammatory responses,” Immunology and Cell Biology, vol. 92, no. 9, pp. 761–769, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. R. L. Bottrel, Y. L. Yang, D. E. Levy, M. Tomai, and L. F. Reis, “The immune response modifier imiquimod requires STAT-1 for induction of interferon, interferon-stimulated genes, and interleukin-6,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 4, pp. 856–861, 1999. View at Google Scholar
  14. Z. H. Zhou, P. Chaturvedi, Y. L. Han et al., “IFN-gamma induction of the human monocyte chemoattractant protein (hMCP)-1 gene in astrocytoma cells: functional interaction between an IFN-gamma-activated site and a GC-rich element,” Journal of Immunology, vol. 160, no. 8, pp. 3908–3916, 1998. View at Google Scholar
  15. V. T. Nguyen and E. N. Benveniste, “Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages,” The Journal of Biological Chemistry, vol. 275, no. 31, pp. 23674–23684, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Akira, “Functional roles of STAT family proteins: lessons from knockout mice,” Stem Cells, vol. 17, no. 3, pp. 138–146, 1999. View at Publisher · View at Google Scholar
  17. M. H. Heim, “The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus,” Journal of Receptor and Signal Transduction Research, vol. 19, no. 1–4, pp. 75–120, 1999. View at Publisher · View at Google Scholar
  18. R. Di, M. T. Huang, and C. T. Ho, “Anti-inflammatory activities of mogrosides from Momordica grosvenori in murine macrophages and a murine ear edema model,” Journal of Agricultural and Food Chemistry, vol. 59, no. 13, pp. 7474–7481, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Mandal, P. Fu, and A. D. Levine, “REDOX regulation of IL-13 signaling in intestinal epithelial cells: usage of alternate pathways mediates distinct gene expression patterns,” Cellular Signalling, vol. 22, no. 10, pp. 1485–1494, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. I. Liochev, “Reactive oxygen species and the free radical theory of aging,” Free Radical Biology & Medicine, vol. 60, pp. 1–4, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. G. Rhee, “Cell signaling. H2O2, a necessary evil for cell signaling,” Science, vol. 312, no. 5782, pp. 1882-1883, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. J. D. Lambeth, T. Kawahara, and B. Diebold, “Regulation of Nox and Duox enzymatic activity and expression,” Free Radical Biology & Medicine, vol. 43, no. 3, pp. 319–331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Dröge, “Free radicals in the physiological control of cell function,” Physiological Reviews, vol. 82, no. 1, pp. 47–95, 2002. View at Publisher · View at Google Scholar
  24. Y. S. Bae, H. Oh, S. G. Rhee, and Y. D. Yoo, “Regulation of reactive oxygen species generation in cell signaling,” Molecules and Cells, vol. 32, no. 6, pp. 491–509, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. W. Ryter, H. P. Kim, A. Hoetzel et al., “Mechanisms of cell death in oxidative stress,” Antioxidants & Redox Signaling, vol. 9, no. 1, pp. 49–89, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. B. M. Babior and W. A. Peters, “The O2-producing enzyme of human neutrophils. Further properties,” The Journal of Biological Chemistry, vol. 256, no. 5, pp. 2321–2323, 1981. View at Google Scholar
  27. H. Sumimoto, K. Miyano, and R. Takeya, “Molecular composition and regulation of the Nox family NAD(P)H oxidases,” Biochemical and Biophysical Research Communications, vol. 338, no. 1, pp. 677–686, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Hultqvist, L. M. Olsson, K. A. Gelderman, and R. Holmdahl, “The protective role of ROS in autoimmune disease,” Trends in Immunology, vol. 30, no. 5, pp. 201–208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Li, L. M. Fan, M. R. Christie, and A. M. Shah, “Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4,” Molecular and Cellular Biology, vol. 25, no. 6, pp. 2320–2330, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Qi, Y. Xin, Y. Guo et al., “Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways,” International Immunopharmacology, vol. 12, no. 1, pp. 278–287, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. E. Abdelmageed, M. S. El-Awady, and G. M. Suddek, “Apocynin ameliorates endotoxin-induced acute lung injury in rats,” International Immunopharmacology, vol. 30, pp. 163–170, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Singh, V. Singh, R. L. Tiwari et al., “The IRAK-ERK-p67phox-Nox-2 axis mediates TLR4, 2-induced ROS production for IL-1β transcription and processing in monocytes,” Cellular & Molecular Immunology, vol. 13, no. 6, pp. 745–763, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. H. S. Kim and M. S. Lee, “Essential role of STAT1 in caspase-independent cell death of activated macrophages through the p38 mitogen-activated protein kinase/STAT1/reactive oxygen species pathway,” Molecular and Cellular Biology, vol. 25, no. 15, pp. 6821–6833, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. C. S. Yang, J. J. Kim, S. J. Lee et al., “TLR3-triggered reactive oxygen species contribute to inflammatory responses by activating signal transducer and activator of transcription-1,” Journal of Immunology, vol. 190, no. 12, pp. 6368–6377, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. H. W. Liao, E. G. Liu, and D. Y. Wang, “Chemical constituents of the bark of Myrica ruba,” Central South Pharmacy., vol. 4, no. 3, pp. 196–199, 2006. View at Google Scholar
  36. Z. G. Liu, Y. C. Zhang, J. I. Shuang, D. L. Meng, and L. I. Xian, “Isolation and identification of constituents from bark of Myrica ruba (Lour.) Sieb.et Zucc,” Journal of Shenyang Pharmaceutical University., vol. 27, no. 1, pp. 34–36, 2010. View at Google Scholar
  37. T. P. T. Cushnie and A. J. Lamb, “Antimicrobial activity of flavonoids,” International Journal of Antimicrobial Agents, vol. 26, no. 5, pp. 343–356, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. F. C. Meotti, A. P. Luiz, M. G. Pizzolatti, C. A. Kassuya, J. B. Calixto, and A. R. Santos, “Analysis of the antinociceptive effect of the flavonoid myricitrin: evidence for a role of the L-arginine-nitric oxide and protein kinase C pathways,” The Journal of Pharmacology and Experimental Therapeutics, vol. 316, no. 2, pp. 789–796, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. E. R. Lee, G. H. Kang, and S. G. Cho, “Effect of flavonoids on human health: old subjects but new challenges,” Recent Patents on Biotechnology, vol. 1, no. 2, pp. 139–150, 2007. View at Publisher · View at Google Scholar
  40. A. Kale, S. Gawande, and S. Kotwal, “Cancer phytotherapeutics: role for flavonoids at the cellular level,” Phytotherapy Research, vol. 22, no. 5, pp. 567–577, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. J. H. Wu, C. Y. Huang, Y. T. Tung, and S. T. Chang, “Online RP-HPLC-DPPH screening method for detection of radical-scavenging phytochemicals from flowers of Acacia confusa,” Journal of Agricultural and Food Chemistry, vol. 56, no. 2, pp. 328–332, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. W. Chen, L. Feng, Y. Shen et al., “Myricitrin inhibits acrylamide-mediated cytotoxicity in human Caco-2 cells by preventing oxidative stress,” BioMed Research International, vol. 2013, no. 6, p. 724183, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. F. C. Meotti, R. Senthilmohan, D. T. Harwood, F. C. Missau, M. G. Pizzolatti, and A. J. Kettle, “Myricitrin as a substrate and inhibitor of myeloperoxidase: implications for the pharmacological effects of flavonoids,” Free Radical Biology & Medicine, vol. 44, no. 1, pp. 109–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Shimosaki, Y. Tsurunaga, H. Itamura, and M. Nakamura, “Anti-allergic effect of the flavonoid myricitrin from Myrica rubra leaf extracts in vitro and in vivo,” Natural Product Research, vol. 25, no. 4, pp. 374–380, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Chen, L. Yang, and T. J. Lee, “Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation,” Biochemical Pharmacology, vol. 59, no. 11, pp. 1445–1457, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. S. K. Heo, H. J. Yun, E. K. Noh, W. H. Park, and S. D. Park, “LPS induces inflammatory responses in human aortic vascular smooth muscle cells via toll-like receptor 4 expression and nitric oxide production,” Immunology Letters, vol. 120, no. 1-2, pp. 57–64, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Minghetti, “Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases,” Journal of Neuropathology and Experimental Neurology, vol. 63, no. 9, pp. 901–910, 2004. View at Publisher · View at Google Scholar
  48. J. B. Kim, A. R. Han, E. Y. Park et al., “Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF-kappaB inactivation in RAW 264.7 macrophage cells,” Biological & Pharmaceutical Bulletin, vol. 30, no. 12, pp. 2345–2351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Zhu, D. X. Wang, W. Zhang et al., “Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-κB,” PloS One, vol. 8, no. 2, article e56407, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. K. J. Kim, K. Y. Yoon, H. S. Yoon, S. R. Oh, and B. Y. Lee, “Brazilein suppresses inflammation through inactivation of IRAK4-NF-κB pathway in LPS-induced Raw264.7 macrophage cells,” International Journal of Molecular Sciences, vol. 16, no. 11, pp. 27589–27598, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. C. S. Lai, J. H. Lee, C. T. Ho et al., “Rosmanol potently inhibits lipopolysaccharide-induced iNOS and COX-2 expression through downregulating MAPK, NF-kappaB, STAT3 and C/EBP signaling pathways,” Journal of Agricultural and Food Chemistry, vol. 57, no. 22, pp. 10990–10998, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Mariathasan and D. M. Monack, “Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation,” Nature Reviews. Immunology, vol. 7, no. 1, pp. 31–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. E. N. Gurzov, W. J. Stanley, E. G. Pappas, H. E. Thomas, and D. J. Gough, “The JAK/STAT pathway in obesity and diabetes,” The FEBS Journal, vol. 283, no. 16, pp. 3002–3015, 2016. View at Publisher · View at Google Scholar · View at Scopus
  54. X. Kou, S. Qi, W. Dai, L. Luo, and Z. Yin, “Arctigenin inhibits lipopolysaccharide-induced iNOS expression in RAW264.7 cells through suppressing JAK-STAT signal pathway,” International Immunopharmacology, vol. 11, no. 8, pp. 1095–1102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Finkel, “Signal transduction by reactive oxygen species,” The Journal of Cell Biology, vol. 194, no. 1, pp. 7–15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Zhang, X. Wang, V. Vikash et al., “ROS and ROS-mediated cellular signaling,” Oxidative Medicine and Cellular Longevity, no. 2016, Article ID 4350965, 18 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. O. Sareila, T. Kelkka, A. Pizzolla, M. Hultqvist, and R. Holmdahl, “NOX2 complex-derived ROS as immune regulators,” Antioxidants & Redox Signaling, vol. 15, no. 8, pp. 2197–2208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. J. El-Benna, P. M. Dang, and M. A. Gougerot-Pocidalo, “Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane,” Seminars in Immunopathology, vol. 30, no. 3, pp. 279–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Chen, C. Bai, and X. Wang, “The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine,” Expert Review of Respiratory Medicine, vol. 4, no. 6, pp. 773–783, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Liu, G. Q. Sun, H. Y. Gao et al., “Angelicin regulates LPS-induced inflammation via inhibiting MAPK/NF-κB pathways,” The Journal of Surgical Research, vol. 185, no. 1, pp. 300–309, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Hiroshima, K. Hsu, N. Tedla et al., “S100A8 induces IL-10 and protects against acute lung injury,” Journal of Immunology, vol. 192, no. 6, pp. 2800–2811, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Fujihara, M. Muroi, K. Tanamoto, T. Suzuki, H. Azuma, and H. Ikeda, “Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex,” Pharmacology & Therapeutics, vol. 100, no. 2, pp. 171–194, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. M. David, E. Petricoin 3rd, C. Benjamin, R. Pine, M. J. Weber, and A. C. Larner, “Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins,” Science, vol. 269, no. 5231, pp. 1721–1723, 1995. View at Publisher · View at Google Scholar
  64. Z. Wen, Z. Zhong, and J. E. Darnell Jr., “Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation,” Cell, vol. 82, no. 2, pp. 241–250, 1995. View at Publisher · View at Google Scholar · View at Scopus
  65. X. Zhang, J. Blenis, H. C. Li, C. Schindler, and S. Chen-Kiang, “Requirement of serine phosphorylation for formation of STAT-promoter complexes,” Science, vol. 267, no. 5206, pp. 1990–1994, 1995. View at Publisher · View at Google Scholar
  66. W. Han, H. Li, J. Cai et al., “NADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-κB activity,” Journal of Immunology, vol. 190, no. 9, pp. 4786–4794, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. H. J. Forman and M. Torres, “Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 12 Part 2, pp. S4–S8, 2002. View at Publisher · View at Google Scholar
  68. G. Y. Lam, J. Huang, and J. H. Brumell, “The many roles of NOX2 NADPH oxidase-derived ROS in immunity,” Seminars in Immunopathology, vol. 32, no. 4, pp. 415–430, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Asehnoune, D. Strassheim, S. Mitra, J. Y. Kim, and E. Abraham, “Involvement of reactive oxygen species in toll-like receptor 4-dependent activation of NF-kappa B,” Journal of Immunology, vol. 172, no. 4, pp. 2522–2529, 2004. View at Publisher · View at Google Scholar
  70. P. E. Shaw, “Could STAT3 provide a link between respiration and cell cycle progression?” Cell Cycle, vol. 9, no. 21, pp. 4294–4296, 2010. View at Publisher · View at Google Scholar · View at Scopus